๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Prognostic Impact of Underlying Liver Fibrosis and Cirrhosis After Curative Resection of Hepatocellular Carcinoma

โœ Scribed by Peter Gassmann; Tilmann Spieker; Joerg Haier; Fabian Schmidt; Wolf Arif Mardin; Norbert Senninger

Publisher
Springer
Year
2010
Tongue
English
Weight
284 KB
Volume
34
Category
Article
ISSN
0364-2313

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Patterns of intrahepatic recurrence afte
Patterns of intrahepatic recurrence after curative resection of hepatocellular carcinoma
โœ Takashi Matsumata; Takashi Kanematsu; Kenji Takenaka; Yasuhiro Yoshida; Takashi ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 371 KB

Using selective angiograms of the liver, we analyzed the patterns of intrahepatic recurrence of hepatocellular carcinomas following curative surgery. In 33 patients with intraheptaic recurrences, seven patients (2 1 %) had a recurrence near the resected hepatic stump. The remaining 26 had either a n

Bone metastases of hepatocellular carcin
Bone metastases of hepatocellular carcinoma after liver resection
โœ Y. Taki; Y. Yamaoka; T. Takayasu; K. Ino; Y. Shimahara; K. Mori; T. Morimoto; K. ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 589 KB

## Abstract Between January 1985 and July 1990, 323 cases of hepatocellular carcinoma underwent liver resection in our department. Bone metastases were found in 12 of these cases (3.7%). Bone metastases were mainly found in vertebral bone (58.3%) and pelvic bone (41.7%). The time interval to the de

Prevention of hepatocellular carcinoma r
Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis
โœ Vincenzo Mazzaferro; Raffaele Romito; Marcello Schiavo; Luigi Mariani; Tiziana C ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 563 KB

Tumor recurrence after resection of hepatocellular carcinoma (HCC) can occur early (<2 years) or late (>2 years) as metastases or de novo tumors. Interferon (IFN) has the potential for chemoprevention against hepatitis C virus (HCV)-related cirrhosis. A predetermined group of 150 HCV RNA-positive pa